Monday May 02, 2022

Episode 5. Global & the European Facilitated Regulatory Pathways

Time-to-market plays a major role in addressing the needs of vulnerable patient groups. Facilitated pathways across the globe accelerate the timelines of innovative drug molecules, allowing fast-tracked approval pathways for essential medicines. Our experts address the necessary requirements of innovators and elaborate on the facilitated Regulatory pathways.

Reference Links

Comments (0)

To leave or reply to comments, please download free Podbean or

No Comments

Copyright 2022 All rights reserved.

Podcast Powered By Podbean